THBC001
Treatment of Advanced Cancer With Amplitude-modulated Electromagnetic Fields of Low Intensity by Means of an Intrabuccal Probe
Sponsor study identifier
interventional
2
1 country
1
Study Start
October 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2006
Actual (reported)Study Completion
December 2007
Actual (reported)In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth. We have identified specific frequencies that may block cancer cell growth. We have developed a device delivering low levels of amplitude-modulated electromagnetic fields. The device is connected to a spoon-like coupler, which is placed in the patient's mouth during treatment. We will conduct a feasibility study consisting of three daily ambulatory treatments until disease progression.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2007
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2004
Date type not reportedThis date has not been verified as actual or estimated.
September 2006
Actual (reported)February 24, 2007
Actual (reported)February 27, 2007
Actual (reported)December 2007
Actual (reported)Safety of daily administration of amplitude-modulated electromagnetic fields in patients with advanced cancer
Complete blood count, comprehensive chemistry profile, tumor markers
Tumor assessment as per RECIST criteria
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Cabinet Médical Avenue de la gare 6
Lausanne, Canton of Vaud, 1012, Switzerland
Barbault A, Costa FP, Bottger B, Munden RF, Bomholt F, Kuster N, Pasche B. Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. J Exp Clin Cancer Res. 2009 Apr 14;28(1):51. doi: 10.1186/1756-9966-28-51.
Boris C Pasche, MD, PhD
Cabinet Médical Avenue de la gare 6
First Submitted
February 24, 2007
First Posted
February 27, 2007
Study Start
October 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2006
Actual (reported)Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors
Contact the study team to confirm eligibility.
Study Completion
December 2007
Actual (reported)Last Updated
June 29, 2011
Record last verified: 2011-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: